Zobrazeno 1 - 10
of 216
pro vyhledávání: '"J.B. Trimbos"'
Publikováno v:
Journal of Gynecologic Surgery. 28:389-398
Objective: The treatment of endometrial cancer is total hysterectomy including bilateral salpingo-oophorectomy. Standard treatment takes away the possibility for fertile women to conceive. This review studies the effectiveness and safety of conservat
Autor:
Gemma G. Kenter, Arko Gorter, Simone Punt, H J M A A Zijlmans, J.B. Trimbos, Gert Jan Fleuren
Publikováno v:
Zijlmans, H J M A A, Punt, S, Fleuren, G J, Trimbos, J B, Kenter, G G & Gorter, A 2012, ' Role of IL-12p40 in cervical carcinoma ', British Journal of Cancer, vol. 107, no. 12, pp. 1956-1962 . https://doi.org/10.1038/bjc.2012.488
British Journal of Cancer, 107(12), 1956-1962
British Journal of Cancer
British Journal of Cancer, 107(12), 1956-1962. Nature Publishing Group
British Journal of Cancer, 107(12), 1956-1962
British Journal of Cancer
British Journal of Cancer, 107(12), 1956-1962. Nature Publishing Group
Cervical cancer is a leading cause of morbidity and mortality among women worldwide, especially in the developing countries (Munoz, 2000; Rock et al, 2000). Infection with oncogenic types of human papillomavirus (HPV) is an important factor in the de
Gynecological oncology surgery has shown substantial progress in recent years. Most of the advances come from gynecologists with full time commitments to gynecological oncology. Jt is important for the general obstetrician-gynecologist to be informed
Publikováno v:
International journal of gynecological cancer, 7(1), 50-57. Wolters Kluwer Health
The objective of this study is to evaluate the possible relevance of vulvar epithelial changes as a risk factor for squamous cell carcinoma of the vulva. The data of 66 women surgically treated for squamous cell carcinoma of the vulva have been analy
Publikováno v:
Gynecologic Oncology. 62:59-66
The prognostic significance of histologic grade, morphometric analysis, and DNA flow cytometry was evaluated in 64 patients with well-differentiated (group A) and 30 patients with moderately and poorly differentiated (group B) early-stage (FIGO stage
Autor:
J.P. Holm, A.C. Drogendijk, Alexander A.W. Peters, J.B. Trimbos, E.H. Witte, A.C.H. Damen, E.A. vd Velde
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology. 66:51-56
Objective: To compare the analgetic efficacy and side-effects of Naproxen and Tramadol following the outpatient VABRA aspiration or hysterosalpingography. Setting: Ninety-one patients from the gynaecology clinics of two university hospitals and one m
Publikováno v:
Journal of Materials Science: Materials in Medicine. 6:41-45
In this study a degradable barrier, composed of a poly(ethyleneglycol) and poly(butyleneterephthalate) copolymer (1000 Polyactive™ 55/45), was investigated for the prevention of postoperative adhesion formation. Three different designs of polymer f
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology. 58:167-171
Although the omentum is extensively used in general, reconstructive and thoracic surgery as a pedicled omentoplasty, little information exists about the utility of such a procedure in general and radical gynecologic surgery. In this paper we review t
Autor:
J. A. Schueler, M.E.L. van der Burg, Gert Jan Fleuren, C.J. Cornelisse, Jo Hermans, J.B. Trimbos
Publikováno v:
Cancer. 71:787-795
Background. The prognosis of patients with early ovarian cancer is good as compared with that of patients with advanced disease. However, there are no methods for predicting prognosis of early ovarian cancer, on which treatment decisions can be based
Autor:
M.E.L. van der Burg, Jan B. Vermorken, A.J. de Meijer, A.P.M. Heintz, M. van Lent, Phb Willemse, A.C.M. van Lindert, J.P. Neijt, Aartsen Ej, J.B. Trimbos, A. van Oosterom, W.W. ten Bokkel Huinink
Publikováno v:
European journal of cancer
In two studies initiated in 1979 and 1981, 377 patients were treated for advanced epithelial ovarian cancer. In the first study patients were randomly assigned to receive Hexa-CAF (hexamethylmelamine, cyclophosphamide, methotrexate, 5-fluorouracil) o